Clinical Trials Browser

Phase 2 × Suspended × Erlotinib Hydrochloride × Clear all

NCT00536770 2007-11-06

A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer

Phase 2 Suspended

Gastrointestinal

Pancreatic Neoplasms